https://www.selleckchem.com/products/msab.html
With the progress of clinical staging, the TNM expression decreased gradually and there were differences between groups (p less then 0.001). Spearman's test analysis found that the decreased TNM staging of LINC01197 increased gradually (r=-0.816, p less then 0.001), and the area under the curve of LINC01197 distinguishing phase I and phase II+phase+III+phase IV was 0.930. The 1-year survival rate and 5-year survival rate of patients in low expression group were lower than those in high expression group (p1 year =0.037, p5 year =0.014). Dis
Like
Comment
Share
